Annual EBITDA
$166.39M$106.12M-38.94%
Summary
- Current Value
- As of today, PACS annual EBITDA is $166.39M, down -38.94% on
- Historical Performance
- PACS annual EBITDA is up +83.83% over the past 3 years, and up +83.83% over the past 5 years
- All-Time High Comparison
- PACS annual EBITDA is currently -38.94% below its historical high of $272.50M set on
- 3-Year Low Comparison
- PACS annual EBITDA is at its 3-year low
- Sector Comparison
- PACS annual EBITDA is higher than 87.68% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $166.39M | -38.9% | +83.8% | +83.8% | +83.8% | |
| Quarterly EBITDA | $100.77M | +193.5% | +53.5% | +53.5% | +53.5% | |
| TTM EBITDA | $341.37M | +79.6% | +420.2% | +420.2% | +420.2% | |
| Price | $41.27 | +212.7% | – | – | – | |
| PE Ratio | 39.80 | +365.5% | – | – | – | |
| Annual Revenue | $4.09B | +31.4% | +250.6% | +250.6% | +250.6% | |
| Annual EPS | $0.36 | -92.2% | -81.5% | -81.5% | -81.5% | |
| Annual EBIT | $125.58M | -49.1% | +50.6% | +50.6% | +50.6% | |
| Annual Net Income | $55.34M | -51.0% | +15.4% | +15.4% | +15.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $272.50M | -38.9% | |
| 5Y | $272.50M | -38.9% | |
| All | $272.50M | -38.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $166.39M | at low | |
| 5Y | $90.51M | +83.8% | |
| All | $90.51M | +83.8% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $166.39M | -38.9% | |
| $272.50M | +8.3% |
| Year | Value | Change |
|---|---|---|
| $251.67M | +178.1% | |
| $90.51M | - |
FAQ
What is the current annual EBITDA of PACS?
As of today, PACS annual EBITDA is $166.39M
What is 1-year change in PACS annual EBITDA?
PACS annual EBITDA is down -38.94% year-over-year
What is 3-year change in PACS annual EBITDA?
PACS annual EBITDA is up +83.83% over the past 3 years
How far is PACS annual EBITDA from its all-time high?
PACS annual EBITDA is currently -38.94% below its historical high of $272.50M set on December 31, 2023
How does PACS annual EBITDA rank versus sector peers?
PACS annual EBITDA is higher than 87.68% of companies in Healthcare sector
When is PACS next annual earnings release?
The next annual earnings release for PACS is on
Quarterly EBITDA
$100.77M$7.02M+7.49%
Summary
- Current Value
- As of today, PACS quarterly EBITDA is $100.77M, up +7.49% on
- Historical Performance
- PACS quarterly EBITDA is up +193.52% year-over-year, and up +53.55% over the past 3 years
- All-Time High Comparison
- PACS quarterly EBITDA is currently -7.97% below its historical high of $109.50M set on
- 3-Year Low Comparison
- PACS quarterly EBITDA is +467.25% above its 3-year low of -$27.44M reached on
- Sector Comparison
- PACS quarterly EBITDA is higher than 88.87% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $100.77M | +7.5% | +193.5% | +53.5% | +53.5% | |
| Annual EBITDA | $166.39M | – | -38.9% | +83.8% | +83.8% | |
| TTM EBITDA | $341.37M | +24.2% | +79.6% | +420.2% | +420.2% | |
| Price | $41.27 | +215.0% | +212.7% | – | – | |
| PE Ratio | 39.80 | +215.1% | +365.5% | – | – | |
| Quarterly Revenue | $1.34B | +2.7% | +31.0% | +89.8% | +89.8% | |
| Quarterly EPS | $0.32 | +3.3% | +216.0% | +29.0% | +29.0% | |
| Quarterly EBIT | $86.37M | +7.2% | +262.8% | +44.4% | +44.4% | |
| Quarterly Net Income | $52.33M | +2.7% | +222.8% | +39.2% | +39.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $100.77M | at high | |
| 3Y | $109.50M | -8.0% | |
| 5Y | $109.50M | -8.0% | |
| All | $109.50M | -8.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $60.98M | +65.3% | |
| 3Y | -$27.44M | +467.3% | |
| 5Y | -$27.44M | +467.3% | |
| All | -$27.44M | +467.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of PACS?
As of today, PACS quarterly EBITDA is $100.77M
What is PACS quarterly EBITDA most recent change?
PACS quarterly EBITDA was up +7.49% on September 30, 2025
What is 1-year change in PACS quarterly EBITDA?
PACS quarterly EBITDA is up +193.52% year-over-year
How far is PACS quarterly EBITDA from its all-time high?
PACS quarterly EBITDA is currently -7.97% below its historical high of $109.50M set on December 1, 2023
How does PACS quarterly EBITDA rank versus sector peers?
PACS quarterly EBITDA is higher than 88.87% of companies in Healthcare sector
When is PACS next earnings release?
The next earnings release for PACS is on
TTM EBITDA
$341.37M$66.44M+24.17%
Summary
- Current Value
- As of today, PACS TTM EBITDA is $341.37M, up +24.17% on
- Historical Performance
- PACS TTM EBITDA is up +79.64% year-over-year, and up +420.16% over the past 3 years
- All-Time High Comparison
- PACS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- PACS TTM EBITDA is +420.16% above its 3-year low of $65.63M reached on
- Sector Comparison
- PACS TTM EBITDA is higher than 88.42% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $341.37M | +24.2% | +79.6% | +420.2% | +420.2% | |
| Annual EBITDA | $166.39M | – | -38.9% | +83.8% | +83.8% | |
| Quarterly EBITDA | $100.77M | +7.5% | +193.5% | +53.5% | +53.5% | |
| Price | $41.27 | +215.0% | +212.7% | – | – | |
| PE Ratio | 39.80 | +215.1% | +365.5% | – | – | |
| TTM Revenue | $5.14B | +6.6% | +37.6% | +625.4% | +625.4% | |
| TTM EPS | $1.04 | +26.5% | -61.4% | +320.4% | +320.4% | |
| TTM EBIT | $288.17M | +27.7% | +86.1% | +381.9% | +381.9% | |
| TTM Net Income | $167.87M | +27.4% | +215.0% | +346.5% | +346.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $341.37M | at high | |
| 3Y | $341.37M | at high | |
| 5Y | $341.37M | at high | |
| All | $341.37M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $153.74M | +122.0% | |
| 3Y | $65.63M | +420.2% | |
| 5Y | $65.63M | +420.2% | |
| All | $65.63M | +420.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of PACS?
As of today, PACS TTM EBITDA is $341.37M
What is PACS TTM EBITDA most recent change?
PACS TTM EBITDA was up +24.17% on September 30, 2025
What is 1-year change in PACS TTM EBITDA?
PACS TTM EBITDA is up +79.64% year-over-year
How far is PACS TTM EBITDA from its all-time high?
PACS TTM EBITDA is currently at its all-time high
How does PACS TTM EBITDA rank versus sector peers?
PACS TTM EBITDA is higher than 88.42% of companies in Healthcare sector
When is PACS next earnings release?
The next earnings release for PACS is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- PACS Official Website pacs.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/2001184/000200118425000071/0002001184-25-000071-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/2001184/000200118425000068/0002001184-25-000068-index.htm
- PACS Profile on Yahoo Finance finance.yahoo.com/quote/PACS
- PACS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pacs